Anna Long leads enterprise strategy and innovation for PPD. In this position, she is responsible for advancing PPD’s strategy and ensuring long-term competitiveness. Long, who joined PPD in 2015, has served in several prior roles, most recently as global head of commercial for Evidera, PPD’s peri- and post-approval business unit specializing in evidence-based solutions to optimize the patient access and commercial potential of its clients’ products.
Before joining PPD, Long spent much of her career in management consulting. At Monitor Group, she focused on corporate strategy, portfolio optimization, expansions into new business lines and markets, and cost optimization. She has worked across several different industries, including health care and industrial chemicals.
Long earned a bachelor’s degree in international business and economics from Vanderbilt University and an MBA from Harvard Business School.